SHL Medical AG
SHL Group provides solutions for the design, development and manufacture of drug delivery devices such as autoinjectors, pen injectors, and inhalers. It offers final assembly, labelling and packaging services for its injection products, and services for medtech and patient care solutions.
SHL Group is a solutions provider in the design, development and manufacture of a variety of products in the pharmaceutical and healthcare industries. In drug delivery, the company’s products include re-usable and disposable injectors that can accommodate high volumes and high viscosities, and can be enhanced with digital technology.
SHL Group consists of:
- SHL Medical, which designs, develops and manufactures advanced drug delivery devices, and also provides final assembly, labelling and packaging services for pharmaceutical and biotech companies worldwide
- SHL Healthcare, which develops and manufactures equipment solutions for home, hospital and long-term care
- SHL Technologies, which provides contract manufacturing and engineering services for the production of complex medtech and industrial products.
SHL is best known for its portfolio of autoinjectors and technologies for self-injection, including the Molly® family of autoinjectors, the Rotaject® technology for high-volume and high-viscosity formulations, and the Needle Isolation Technology (NIT®), a unique safety solution for cartridge-based auto injectors.
SHL Group is privately owned. It was founded in 1989 and now employs more than 4,000 people globally. SHL works with the majority of the world’s top 25 largest pharma companies.